Ontology highlight
ABSTRACT: Introduction
Acute antibody-mediated rejection (ABMR) is an important threat to renal allograft survival in the early transplant period and the major single cause of graft loss in the first postoperative year. Semi-selective immunoadsorption (IA) remains one of the commonly applied treatments in ABMR, reducing allo-reactive antibody load. Adding double filtration plasmapheresis (DFPP) to IA might enhance therapeutic efficacy by also addressing innate humoral effectors like complement factors.Methods
Four patients with ABMR were treated with DFPP + IA. Clinical, histological, and immunological data and adverse events were retrospectively collected.Results
Here we present four high-risk treatment-refractory ABMR cases with C1q-binding donor-specific antibodies and his
SUBMITTER: Russwurm M
PROVIDER: S-EPMC10273878 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature